The Use of Intravascular Paclitaxel for the Treatment of Upper-Arm Arteriovenous Access Fistula Stenosis: A Randomized Study

Trial Profile

The Use of Intravascular Paclitaxel for the Treatment of Upper-Arm Arteriovenous Access Fistula Stenosis: A Randomized Study

Discontinued
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2015

At a glance

  • Drugs Paclitaxel (Primary) ; Heparin
  • Indications Vascular restenosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Sep 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 04 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top